Here, we identified high levels of phosphopeptides from downstream mediators of these pathways, including PI3K p85β, PDK1, GSK3β, MEK2, ERK1, and ERK2, in MYCN-amplified neuroblastoma cells. Here, MAPK3 is linked to neuroblastoma.